Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhage

Thirty-seven patients with intractable bladder hemorrhage were treated with intravesical epsilon aminocaproic acid (EACH). Radiation cystitis and cyclophosphamide-induced cystitis were the two most common causes of intractable bladder hemorrhage. Thirty-four patients responded to treatment. No side...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Urology (Ridgewood, N.J.) N.J.), 1992-09, Vol.40 (3), p.227-229
Hauptverfasser:	Singh, Inderjit, Laungani, Gobind B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intravesical Adult Aged Aminocaproic Acid - administration & dosage Aminocaproic Acid - therapeutic use Biological and medical sciences Ent. Stomatology Female Hemorrhage - drug therapy Hemorrhage - etiology Humans Male Medical sciences Middle Aged Pharmacology. Drug treatments Therapeutic Irrigation Urinary Bladder Diseases - drug therapy Urinary Bladder Diseases - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Thirty-seven patients with intractable bladder hemorrhage were treated with intravesical epsilon aminocaproic acid (EACH). Radiation cystitis and cyclophosphamide-induced cystitis were the two most common causes of intractable bladder hemorrhage. Thirty-four patients responded to treatment. No side effects were noted. Intravesical EACA appears to be a safe and effective method to control intractable bladder hemorrhage.
ISSN:	0090-4295 1527-9995
DOI:	10.1016/0090-4295(92)90479-G